Literature DB >> 10466173

The pulmonary cachexia syndrome: aspects of energy balance.

J Congleton1.   

Abstract

The present paper reviews current knowledge of the pulmonary cachexia syndrome with reference to chronic obstructive pulmonary disease (COPD). Aspects of incidence, aetiology and management are discussed. Malnutrition occurs in approximately one-quarter to one-third of patients with moderate to severe COPD. Both fat mass and fat-free mass become depleted. Loss of fat-free mass is the more important and appears to be due to a depression of protein synthesis. Weight loss is an independent prognostic indicator of mortality, and is associated with increased morbidity and decreased health-related quality of life. The aetiology of malnutrition in COPD is not well understood. Reduced food intake does not seem to be the primary cause. Resting energy expenditure (REE) is elevated in a proportion of patients and probably contributes to negative energy balance. Measurement of actual REE is helpful when considering the adequacy of nutritional supplementation. The underlying reason for a hypermetabolic state is not known. Although weight-losing COPD patients are not catabolic, nutritional supplementation alone does not appear to reverse the loss of fat-free mass. Strategies involving nutritional supplementation in combination with a second intervention are being explored, and there are some encouraging results using anabolic hormones.

Entities:  

Mesh:

Year:  1999        PMID: 10466173     DOI: 10.1017/s0029665199000439

Source DB:  PubMed          Journal:  Proc Nutr Soc        ISSN: 0029-6651            Impact factor:   6.297


  14 in total

1.  Frailty Phenotypes, Disability, and Outcomes in Adult Candidates for Lung Transplantation.

Authors:  Jonathan P Singer; Joshua M Diamond; Cynthia J Gries; Jamiela McDonnough; Paul D Blanc; Rupal Shah; Monica Y Dean; Beverly Hersh; Paul J Wolters; Sofya Tokman; Selim M Arcasoy; Kristy Ramphal; John R Greenland; Nancy Smith; Pricilla Heffernan; Lori Shah; Pavan Shrestha; Jeffrey A Golden; Nancy P Blumenthal; Debbie Huang; Joshua Sonett; Steven Hays; Michelle Oyster; Patricia P Katz; Hilary Robbins; Melanie Brown; Lorriana E Leard; Jasleen Kukreja; Matthew Bacchetta; Errol Bush; Frank D'Ovidio; Melanie Rushefski; Kashif Raza; Jason D Christie; David J Lederer
Journal:  Am J Respir Crit Care Med       Date:  2015-12-01       Impact factor: 21.405

2.  Body mass index, respiratory conditions, asthma, and chronic obstructive pulmonary disease.

Authors:  Yong Liu; Roy A Pleasants; Janet B Croft; Njira Lugogo; Jill Ohar; Khosrow Heidari; Charlie Strange; Anne G Wheaton; David M Mannino; Monica Kraft
Journal:  Respir Med       Date:  2015-05-16       Impact factor: 3.415

Review 3.  Cancer cachexia, mechanism and treatment.

Authors:  Tomoyoshi Aoyagi; Krista P Terracina; Ali Raza; Hisahiro Matsubara; Kazuaki Takabe
Journal:  World J Gastrointest Oncol       Date:  2015-04-15

4.  Body composition and mortality after adult lung transplantation in the United States.

Authors:  Jonathan P Singer; Eric R Peterson; Mark E Snyder; Patricia P Katz; Jeffrey A Golden; Frank D'Ovidio; Matthew Bacchetta; Joshua R Sonett; Jasleen Kukreja; Lori Shah; Hilary Robbins; Kristin Van Horn; Rupal J Shah; Joshua M Diamond; Nancy Wickersham; Li Sun; Steven Hays; Selim M Arcasoy; Scott M Palmer; Lorraine B Ware; Jason D Christie; David J Lederer
Journal:  Am J Respir Crit Care Med       Date:  2014-11-01       Impact factor: 21.405

5.  Resting energy expenditure and protein turnover are increased in patients with severe chronic obstructive pulmonary disease.

Authors:  Christina C Kao; Jean W-C Hsu; Venkata Bandi; Nicola A Hanania; Farrah Kheradmand; Farook Jahoor
Journal:  Metabolism       Date:  2011-05-06       Impact factor: 8.694

6.  Cachexia as a major underestimated and unmet medical need: facts and numbers.

Authors:  Stephan von Haehling; Stefan D Anker
Journal:  J Cachexia Sarcopenia Muscle       Date:  2010-10-26       Impact factor: 12.910

Review 7.  Reversal of chronic obstructive pulmonary disease-associated weight loss : are there pharmacological treatment options?

Authors:  Jean K Berry; Charles Baum
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 8.  Pathobiology of frailty in lung disease.

Authors:  Brittany Koons; John R Greenland; Joshua M Diamond; Jonathan P Singer
Journal:  Transl Res       Date:  2020-05-03       Impact factor: 7.012

9.  Resting energy expenditure and carbohydrate oxidation are higher in elderly patients with COPD: a case control study.

Authors:  Bruna Rubi Ramires; Erick Prado de Oliveira; Gustavo Duarte Pimentel; Kátia Cristina Portero McLellan; Darlan Muller Nakato; Márcia Maria Faganello; Maurício Longo Galhardo; Luciene de Souza Venâncio
Journal:  Nutr J       Date:  2012-06-06       Impact factor: 3.271

10.  Cancer cachexia: impact, mechanisms and emerging treatments.

Authors:  Vanessa C Vaughan; Peter Martin; Paul A Lewandowski
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-10-25       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.